Both Parents at Risk for Depression Following Birth

Physicians have screened new and expectant mothers for perinatal depression for years. But what about fathers? A new systematic review and meta-analysis suggests it’s time for healthcare providers to ask both parents about any mental health symptoms before and after their baby is born. Dr Kara Smythe “We are screening most mothers for signs of … Read more

At-Home Vagus Nerve Stimulation Promising for Postpartum Depression

At-home, noninvasive auricular vagus nerve stimulation (aVNS) therapy is well-tolerated and associated with a significant reduction in postpartum depressive and anxiety symptoms, new research suggests. In a small proof-of-concept pilot study of 25 women with postpartum depression receiving 6 weeks of daily aVNS treatment, results showed that 74% achieved response and 61% achieved remission, as … Read more

Is Subfertility Linked With Postpartum Mental Illness?

Mothers with previous subfertility have increased risk for postpartum mental illness, compared with mothers who conceived spontaneously, according to a new study. In a population-based cohort study that examined almost 800,000 births, the adjusted relative risk (RR) for postpartum mental illness was 1.14 in women with subfertility, compared with women without reproductive assistance. The magnitude … Read more

US Docs at Double the Risk of Postpartum Depression

One in four new mothers who are physicians report experiencing postpartum depression, a rate twice that of the general population, according to new survey findings presented at the American College of Obstetricians and Gynecologists (ACOG) 2022 Annual Meeting. The survey results weren’t all grim. More than three fourths (78%) of new mothers reported meeting their … Read more

Novel Medication Tied to Better QoL in Major Depression

DENVER ― An investigational once-daily oral neuroactive steroid is linked to significant improvement in quality of life (QoL) and well-being in patients with major depressive disorder (MDD), new research shows. In a phase 3 trial that included more than 500 adult patients with MDD, those who received zuranolone for 14 days showed greater improvement at … Read more